You are here

07-04-2020 | © Lunds university 4 mins read

A repairable brain: cell reprogramming to halt neurodegenerative disease

What if damaged brain cells could be replaced? ERC grantee Malin Parmar has developed innovative genetic reprogramming techniques that can produce new brain cells from other types of cells in the body, opening up new therapeutic pathways to combat disorders such as Parkinson’s and Alzheimer’s.

24-06-2019 | © istockphotos.com 2 mins read

Microbiota: a cure for obesity?

Effective treatment for obesity remains a challenge and the only intervention proven to maintain weight loss is bariatric surgery. Intrigued by the beneficial effect that this procedure has on the composition of gut microbiota, Dr Fredrik Bäckhed explores the possibility of mimicking these changes to develop a treatment for obesity that won’t require going under the knife.

08-05-2019 | © picture 3 mins read

Is political participation contagious?

ELECTION SERIES #7

Why are some people more likely to vote or stand for election than others? Researchers based in Sweden are doing some deep data diving to find out how our social surroundings and our genes influence political participation.

16-08-2018 | @ iStock 3 mins read

The double life of water

Water is a peculiar liquid. In fact, it's thanks to some of its peculiarities that our "blue" planet looks the way it does, and that life has evolved most of the characteristics we recognise today. ERC grantee Prof. Anders Nilsson has made his career out of studying water, in particular trying to understand the secret double life water leads at extremely cold temperatures.

11-05-2017 | Portrait and illustration: Photo Evolutionary Biology group (Isabel Gordo) | llustration: Macrophages with Escherichia coli 3 mins read

New knowledge to fight back against antibiotic resistance

The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.

01-04-2017 | © picture 2 mins read

Frontier science and business that makes a difference

Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.

Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."

30-03-2017 | © picture 2 mins read

Together, we can achieve a lot

Ole Kamstrup, MD., MSc., is a pensioner and lives north of Copenhagen in Denmark. He has been diagnosed with Parkinson's disease ten years ago. Since 2013, Mr Kamstrup has been in contact with Professor Deniz Kirik, a neuroscientist at Lund University in Sweden. Professor Kirik, who was awarded an ERC Starting Grant in 2009, develops new therapies for Parkinson’s disease, using viral vectors to deliver therapeutic genes to the brain. An ERC Proof of Concept grant enabled him to start carrying out a market evaluation and writing a business plan for the promising therapy.

Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."

29-06-2016 | © picture 2 mins read

Stem cells: from frontier research project to promising spin-off company

Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.

30-10-2015 | image © Istockphoto 2 mins read

Animals "peer-pressured" into reacting to danger

ERC grantee Marta Moita and her team use cutting-edge experimental procedures to investigate how rats and flies learn to appropriately respond to danger from other individuals. The results of her study may teach us a lot about our own brains, and shed light on diseases that impair social behaviour.